世界の骨粗しょう症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Osteoporosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4633
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、骨粗しょう症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、副甲状腺ホルモン療法、カルシトニン、選択的エストロゲン阻害剤モジュレーター（SERM））、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・骨粗しょう症治療の市場動向
・企業の競争状況、市場シェア
・骨粗しょう症治療の種類別市場規模と予測2016-2027（ビスフォスフォネート、副甲状腺ホルモン療法、カルシトニン、選択的エストロゲン阻害剤モジュレーター（SERM））
・骨粗しょう症治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・骨粗しょう症治療の北米市場規模2016-2027（アメリカ、カナダ）
・骨粗しょう症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・骨粗しょう症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・骨粗しょう症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・骨粗しょう症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan Plc、Amgen, Inc.、Actavis Plc.、Eli Lilly and Company、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Pharmaceutical Ltd.、Merck & Co AG、Novartis AG、Novo Nordisk A/S、Pfizer, Inc.、Teva Pharmaceuticals Industries Ltd.）
・結論

Osteoporosis is a bone disease causing loss of bone density that occurs with age. It leads to million broken bones each year, and thus major reason of fractures, spinal problems, back pain, and loss of independence.

Market Analysis and Insights: Global Osteoporosis Treatment Market
The global Osteoporosis Treatment market size is projected to reach US$ 12380 million by 2027, from US$ 10340 million in 2020, at a CAGR of 2.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteoporosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteoporosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteoporosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteoporosis Treatment market.

Global Osteoporosis Treatment Scope and Market Size
Osteoporosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Parathyroid Hormone Therapy
Calcitonin
Selective Estrogen Inhibitors Modulator (SERM)

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc
Amgen, Inc.
Actavis Plc.
Eli Lilly and Company
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Pharmaceutical Ltd.
Merck & Co AG
Novartis AG
Novo Nordisk A/S
Pfizer, Inc.
Teva Pharmaceuticals Industries Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoporosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bisphosphonates
1.2.3 Parathyroid Hormone Therapy
1.2.4 Calcitonin
1.2.5 Selective Estrogen Inhibitors Modulator (SERM)
1.3 Market by Application
1.3.1 Global Osteoporosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Osteoporosis Treatment Market Perspective (2016-2027)
2.2 Osteoporosis Treatment Growth Trends by Regions
2.2.1 Osteoporosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Osteoporosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Osteoporosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Osteoporosis Treatment Industry Dynamic
2.3.1 Osteoporosis Treatment Market Trends
2.3.2 Osteoporosis Treatment Market Drivers
2.3.3 Osteoporosis Treatment Market Challenges
2.3.4 Osteoporosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Osteoporosis Treatment Players by Revenue
3.1.1 Global Top Osteoporosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Osteoporosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Osteoporosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Osteoporosis Treatment Revenue
3.4 Global Osteoporosis Treatment Market Concentration Ratio
3.4.1 Global Osteoporosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoporosis Treatment Revenue in 2020
3.5 Osteoporosis Treatment Key Players Head office and Area Served
3.6 Key Players Osteoporosis Treatment Product Solution and Service
3.7 Date of Enter into Osteoporosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoporosis Treatment Breakdown Data by Type
4.1 Global Osteoporosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Osteoporosis Treatment Forecasted Market Size by Type (2022-2027)

5 Osteoporosis Treatment Breakdown Data by Application
5.1 Global Osteoporosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Osteoporosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Osteoporosis Treatment Market Size (2016-2027)
6.2 North America Osteoporosis Treatment Market Size by Type
6.2.1 North America Osteoporosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Osteoporosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Osteoporosis Treatment Market Size by Type (2016-2027)
6.3 North America Osteoporosis Treatment Market Size by Application
6.3.1 North America Osteoporosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Osteoporosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Osteoporosis Treatment Market Size by Application (2016-2027)
6.4 North America Osteoporosis Treatment Market Size by Country
6.4.1 North America Osteoporosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Osteoporosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Osteoporosis Treatment Market Size (2016-2027)
7.2 Europe Osteoporosis Treatment Market Size by Type
7.2.1 Europe Osteoporosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Osteoporosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Osteoporosis Treatment Market Size by Type (2016-2027)
7.3 Europe Osteoporosis Treatment Market Size by Application
7.3.1 Europe Osteoporosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Osteoporosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Osteoporosis Treatment Market Size by Application (2016-2027)
7.4 Europe Osteoporosis Treatment Market Size by Country
7.4.1 Europe Osteoporosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Osteoporosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Osteoporosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Osteoporosis Treatment Market Size by Type
8.2.1 Asia-Pacific Osteoporosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Osteoporosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Osteoporosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Osteoporosis Treatment Market Size by Application
8.3.1 Asia-Pacific Osteoporosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Osteoporosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Osteoporosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Osteoporosis Treatment Market Size by Region
8.4.1 Asia-Pacific Osteoporosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Osteoporosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Osteoporosis Treatment Market Size (2016-2027)
9.2 Latin America Osteoporosis Treatment Market Size by Type
9.2.1 Latin America Osteoporosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Osteoporosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Osteoporosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Osteoporosis Treatment Market Size by Application
9.3.1 Latin America Osteoporosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Osteoporosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Osteoporosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Osteoporosis Treatment Market Size by Country
9.4.1 Latin America Osteoporosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Osteoporosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Osteoporosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Osteoporosis Treatment Market Size by Type
10.2.1 Middle East & Africa Osteoporosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Osteoporosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Osteoporosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Osteoporosis Treatment Market Size by Application
10.3.1 Middle East & Africa Osteoporosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Osteoporosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Osteoporosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Osteoporosis Treatment Market Size by Country
10.4.1 Middle East & Africa Osteoporosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Osteoporosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Osteoporosis Treatment Introduction
11.1.4 Allergan Plc Revenue in Osteoporosis Treatment Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Details
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Osteoporosis Treatment Introduction
11.2.4 Amgen, Inc. Revenue in Osteoporosis Treatment Business (2016-2021)
11.2.5 Amgen, Inc. Recent Development
11.3 Actavis Plc.
11.3.1 Actavis Plc. Company Details
11.3.2 Actavis Plc. Business Overview
11.3.3 Actavis Plc. Osteoporosis Treatment Introduction
11.3.4 Actavis Plc. Revenue in Osteoporosis Treatment Business (2016-2021)
11.3.5 Actavis Plc. Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Osteoporosis Treatment Introduction
11.4.4 Eli Lilly and Company Revenue in Osteoporosis Treatment Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 F. Hoffmann La Roche Ltd.
11.5.1 F. Hoffmann La Roche Ltd. Company Details
11.5.2 F. Hoffmann La Roche Ltd. Business Overview
11.5.3 F. Hoffmann La Roche Ltd. Osteoporosis Treatment Introduction
11.5.4 F. Hoffmann La Roche Ltd. Revenue in Osteoporosis Treatment Business (2016-2021)
11.5.5 F. Hoffmann La Roche Ltd. Recent Development
11.6 GlaxoSmithKline Pharmaceutical Ltd.
11.6.1 GlaxoSmithKline Pharmaceutical Ltd. Company Details
11.6.2 GlaxoSmithKline Pharmaceutical Ltd. Business Overview
11.6.3 GlaxoSmithKline Pharmaceutical Ltd. Osteoporosis Treatment Introduction
11.6.4 GlaxoSmithKline Pharmaceutical Ltd. Revenue in Osteoporosis Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Pharmaceutical Ltd. Recent Development
11.7 Merck & Co AG
11.7.1 Merck & Co AG Company Details
11.7.2 Merck & Co AG Business Overview
11.7.3 Merck & Co AG Osteoporosis Treatment Introduction
11.7.4 Merck & Co AG Revenue in Osteoporosis Treatment Business (2016-2021)
11.7.5 Merck & Co AG Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Osteoporosis Treatment Introduction
11.8.4 Novartis AG Revenue in Osteoporosis Treatment Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Novo Nordisk A/S
11.9.1 Novo Nordisk A/S Company Details
11.9.2 Novo Nordisk A/S Business Overview
11.9.3 Novo Nordisk A/S Osteoporosis Treatment Introduction
11.9.4 Novo Nordisk A/S Revenue in Osteoporosis Treatment Business (2016-2021)
11.9.5 Novo Nordisk A/S Recent Development
11.10 Pfizer, Inc.
11.10.1 Pfizer, Inc. Company Details
11.10.2 Pfizer, Inc. Business Overview
11.10.3 Pfizer, Inc. Osteoporosis Treatment Introduction
11.10.4 Pfizer, Inc. Revenue in Osteoporosis Treatment Business (2016-2021)
11.10.5 Pfizer, Inc. Recent Development
11.11 Teva Pharmaceuticals Industries Ltd.
11.11.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.11.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.11.3 Teva Pharmaceuticals Industries Ltd. Osteoporosis Treatment Introduction
11.11.4 Teva Pharmaceuticals Industries Ltd. Revenue in Osteoporosis Treatment Business (2016-2021)
11.11.5 Teva Pharmaceuticals Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Osteoporosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Parathyroid Hormone Therapy
Table 4. Key Players of Calcitonin
Table 5. Key Players of Selective Estrogen Inhibitors Modulator (SERM)
Table 6. Global Osteoporosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Osteoporosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Osteoporosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Osteoporosis Treatment Market Share by Regions (2016-2021)
Table 10. Global Osteoporosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Osteoporosis Treatment Market Share by Regions (2022-2027)
Table 12. Osteoporosis Treatment Market Trends
Table 13. Osteoporosis Treatment Market Drivers
Table 14. Osteoporosis Treatment Market Challenges
Table 15. Osteoporosis Treatment Market Restraints
Table 16. Global Osteoporosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Osteoporosis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Osteoporosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Treatment as of 2020)
Table 19. Ranking of Global Top Osteoporosis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Osteoporosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Osteoporosis Treatment Product Solution and Service
Table 23. Date of Enter into Osteoporosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Osteoporosis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Osteoporosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Osteoporosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Osteoporosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Osteoporosis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Osteoporosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Osteoporosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Osteoporosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Osteoporosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Osteoporosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Osteoporosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Osteoporosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Osteoporosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Osteoporosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Osteoporosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Osteoporosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Osteoporosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Osteoporosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Osteoporosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Osteoporosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Osteoporosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Osteoporosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Osteoporosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Osteoporosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Osteoporosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Osteoporosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Osteoporosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Osteoporosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Osteoporosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Osteoporosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Osteoporosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Osteoporosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Osteoporosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Plc Company Details
Table 64. Allergan Plc Business Overview
Table 65. Allergan Plc Osteoporosis Treatment Product
Table 66. Allergan Plc Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 67. Allergan Plc Recent Development
Table 68. Amgen, Inc. Company Details
Table 69. Amgen, Inc. Business Overview
Table 70. Amgen, Inc. Osteoporosis Treatment Product
Table 71. Amgen, Inc. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 72. Amgen, Inc. Recent Development
Table 73. Actavis Plc. Company Details
Table 74. Actavis Plc. Business Overview
Table 75. Actavis Plc. Osteoporosis Treatment Product
Table 76. Actavis Plc. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 77. Actavis Plc. Recent Development
Table 78. Eli Lilly and Company Company Details
Table 79. Eli Lilly and Company Business Overview
Table 80. Eli Lilly and Company Osteoporosis Treatment Product
Table 81. Eli Lilly and Company Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 82. Eli Lilly and Company Recent Development
Table 83. F. Hoffmann La Roche Ltd. Company Details
Table 84. F. Hoffmann La Roche Ltd. Business Overview
Table 85. F. Hoffmann La Roche Ltd. Osteoporosis Treatment Product
Table 86. F. Hoffmann La Roche Ltd. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 87. F. Hoffmann La Roche Ltd. Recent Development
Table 88. GlaxoSmithKline Pharmaceutical Ltd. Company Details
Table 89. GlaxoSmithKline Pharmaceutical Ltd. Business Overview
Table 90. GlaxoSmithKline Pharmaceutical Ltd. Osteoporosis Treatment Product
Table 91. GlaxoSmithKline Pharmaceutical Ltd. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Pharmaceutical Ltd. Recent Development
Table 93. Merck & Co AG Company Details
Table 94. Merck & Co AG Business Overview
Table 95. Merck & Co AG Osteoporosis Treatment Product
Table 96. Merck & Co AG Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 97. Merck & Co AG Recent Development
Table 98. Novartis AG Company Details
Table 99. Novartis AG Business Overview
Table 100. Novartis AG Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 101. Novartis AG Recent Development
Table 102. Novo Nordisk A/S Company Details
Table 103. Novo Nordisk A/S Business Overview
Table 104. Novo Nordisk A/S Osteoporosis Treatment Product
Table 105. Novo Nordisk A/S Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 106. Novo Nordisk A/S Recent Development
Table 107. Pfizer, Inc. Company Details
Table 108. Pfizer, Inc. Business Overview
Table 109. Pfizer, Inc. Osteoporosis Treatment Product
Table 110. Pfizer, Inc. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 111. Pfizer, Inc. Recent Development
Table 112. Teva Pharmaceuticals Industries Ltd. Company Details
Table 113. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 114. Teva Pharmaceuticals Industries Ltd. Osteoporosis Treatment Product
Table 115. Teva Pharmaceuticals Industries Ltd. Revenue in Osteoporosis Treatment Business (2016-2021) & (US$ Million)
Table 116. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoporosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bisphosphonates Features
Figure 3. Parathyroid Hormone Therapy Features
Figure 4. Calcitonin Features
Figure 5. Selective Estrogen Inhibitors Modulator (SERM) Features
Figure 6. Global Osteoporosis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Osteoporosis Treatment Report Years Considered
Figure 11. Global Osteoporosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Osteoporosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Osteoporosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Osteoporosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Osteoporosis Treatment Market Share by Players in 2020
Figure 16. Global Top Osteoporosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Osteoporosis Treatment Revenue in 2020
Figure 18. Global Osteoporosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Osteoporosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Osteoporosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Osteoporosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Osteoporosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Osteoporosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Osteoporosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Osteoporosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Osteoporosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Osteoporosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Osteoporosis Treatment Market Share by Region (2016-2027)
Figure 40. China Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Osteoporosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Osteoporosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Osteoporosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Osteoporosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Osteoporosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Osteoporosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Osteoporosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Plc Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 60. Amgen, Inc. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 61. Actavis Plc. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 63. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Pharmaceutical Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 65. Merck & Co AG Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 67. Novo Nordisk A/S Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 68. Pfizer, Inc. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 69. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

骨粗鬆症治療薬のグローバル市場2021

Global Osteoporosis Drugs Sales Market Report 2021
QAF27817 2021年4月14日 131Pages
本市場調査資料では、世界の骨粗鬆症治療薬市場について種類別（吸収抑制薬、アナボリック薬）、用途別（女性、男性）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

骨粗鬆症治療薬のグローバル市場2021 Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no sy…
世界のエストロゲン補充療法市場規模・現状・予測（2021年-2027年） Estrogen replacement therapy (ERT) is a type of hormone replacement therapy which is used for the treatment or reduction of various symptoms caused as a result of menopause. Market Analysis and Insights: Global Estrogen Replacement Therapy Market The global Estrogen Replacement Therapy market size …
世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年） Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do. With an increase in mental illnesses, there is…
世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…
世界のパジェット病治療市場規模・現状・予測（2021年-2027年） Paget's disease is a chronic condition which interferes with your body's normal bone remodeling process. ... Over time, the disease can cause affected bones to become fragile and misshapen. Paget's disease of bone most commonly occurs in the pelvis, skull, spine and legs. Market Analysis and Insight…